The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Koreshkina M.I.

Headache Treatment Center Scandinavia

Anxiety disorders as a risk factor for sleep disorders and headaches

Authors:

Koreshkina M.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(2): 131‑135

DOI: 10.17116/jnevro2021121021131

Views: 5649

Downloaded: 120

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Koreshkina MI. Anxiety disorders as a risk factor for sleep disorders and headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(2):131‑135. (In Russ.)
https://doi.org/10.17116/jnevro2021121021131

 
МСФ на ЯМ
Close metadata
Recommended articles:
Vali­dation of screening method based on EEG analysis for the risk asse­ssment of psychiatric and beha­vioral diso­rders: a pilot study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):88-96
Features of the clinical picture of affe­ctive diso­rders in women during the meno­pausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79
Resu­lts of a pilot study of the stru­cture and evaluation of the therapy for chro­nic sleep diso­rders in como­rbid patients with chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):118-126
Posttraumatic stress diso­rder clinical guidelines and treatment standards: focus on the symptoms of the psychophysiological arousal. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):58-68
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Mana­gement of patients with inso­mnia and poly­morbidity. A draft of the clinical guidelines. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):39-52
Trait and state anxiety, symptoms of inso­mnia and their influence on daytime functioning in adolescent girls. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):66-71
Impact of bullying on adolescents’ health: asso­ciation with psychosomatic complaints. Russian Journal of Preventive Medi­cine. 2024;(3):52-58
Como­rbid diso­rders and risk factors for neiropathic pain in distal diabetic poly­neuropathy. Russian Journal of Pain. 2024;(2):41-48
Oral seda­tion in pediatric outpatient dentistry. Stomatology. 2024;(3):42-49

Anxiety and related sleep disorders are a problem in modern society. Sleep disorders cover more than 45% of the world’s population and have become a global health problem in recent decades. Numerous studies have shown an association of sleep disorders with pain, depression, and anxiety, as well as a causal relationship between chronic pain and sleep deficits. Patients with headaches are at a higher risk of mood and anxiety disorders than people in the general population; these results are particularly noticeable for patients with chronic daily headache as well as medication overuse headache. This interaction between mood/anxiety problems and medication overuse may be an important factor in chronification of episodic headache. Detection and treatment of comorbid diseases will not only provide better results, but also improve the quality of life of patients. In the treatment of this category of patients, it is possible to use noofen, which improves sleep, cognitive functions, and reduces headache.

Keywords:

anxiety
sleep disorders
headaches

Authors:

Koreshkina M.I.

Headache Treatment Center Scandinavia

Received:

24.11.2020

Accepted:

28.01.2021

List of references:

  1. Stranges S, Tigbe W, Gomez-Olive FX, et al. Sleep problems: an emerging global epidemic? Findings from the INDEPTH WHO-SAGE study among more than 40,000 older adults from 8 countries across Africa and Asia. Sleep. 2012;35(8):1173-1181. https://doi.org/10.5665/sleep.2012
  2. Troxel WM, Buysse DJ, Matthews KA, et al. Sleep symptoms predict the development of the metabolic syndrome. Sleep. 2010;33(12):1633-1640. https://doi.org/10.1093/sleep/33.12.1633
  3. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80(1):40-52.  https://doi.org/10.1016/j.biopsych.2015.05.014.
  4. Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135:10-19.  https://doi.org/10.1016/j.jad.2011.01.011
  5. Meng L, Zheng Y, Hui R. The relationship of sleep duration and insomnia to risk of hypertension incidence: A meta-analysis of prospective cohort studies. Hypertens Res. 2013;36:985-995.  https://doi.org/10.1038/hr.2013.70
  6. Canivet C, Nilsson PM, Lindeberg SI, et al. Insomnia increases risk for cardiovascular events in women and in men with low socioeconomic status: A longitudinal, register-based study. J Psychosom Res. 2014;76:292-299.  https://doi.org/10.1016/j.jpsychores.2014.02.001
  7. Goncalves M, Amici R, Lucas R, et al. Sleepiness at the wheel across Europe: a survey of 19 Countries. J Sleep Res. 2015;24:242-253.  https://doi.org/10.1111/jsr.12267
  8. Sateia MJ. International Classification of Sleep Disorders-Third Edition. Contemporary reviews in sleep medicine. 2014;146(5):1387-1394. https://doi.org/10.1378/chest.14-0970
  9. Insomnia [Internet]. National Institution of Health. Accessed Feb 24, 2021. https://www.nhlbi.nih.gov/health-topics/insomnia
  10. Ojeda B, Salazar A, Calahorro MJ, et al. Understanding the different relationships between mood and sleep disorders in several groups of non-oncological patients with chronic pain. Curr Med Res Opin. 2018;34:669-676.  https://doi.org/10.1080/03007995.2017.1384372
  11. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394-402.  https://doi.org/10.1111/j.1468-2982.2007.01303.x
  12. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006;46:1334-1343. https://doi.org/10.1111/j.1526-4610.2006.00577.x
  13. Borisenkov M, Petrova N, Kasyanova O. Sleep characteristics, chronotype and winter depression in 10—20-year-olds in northern European Russia. J Sleep Res. 2015;24(3):288-295.  https://doi.org/10.1111/jsr.12266
  14. Kalmbach D, Pillai V, Roth T, Draker C. The interplay between daily affect and sleep: a 2-week study of young women. J Sleep Res. 2014;23(6):636-645.  https://doi.org/10.1111/jsr.12190
  15. Guadagni V, Burles F, Ferrara M, Iaria G. The effects of sleep deprivation on emotional empathy. J Sleep Res. 2014;23(6):657-663.  https://doi.org/10.1111/jsr.12192
  16. Lateef T, Witonsky K, He J, Ries Merikangas K. Headaches and sleep problems in US adolescents: Findings from the National Comorbidity Survey — Adolescent Supplement (NCS-A). Cephalalgia. 2019;39(10):1226-1235. https://doi.org/10.1177/0333102419835466
  17. Vendrame M, Kaleyias J, Valencia I, et al. Polysomnographic findings in children with headaches. Pediatr Neurol. 2008;39:6-11.  https://doi.org/10.1016/j.pediatrneurol.2008.03.007
  18. Holland PR, Goadsby PJ. The hypothalamic orexinergic system: Pain and primary headaches. Headache. 2007;47:951-962.  https://doi.org/10.1111/j.1526-4610.2007.00842.x
  19. Brennan KC, Charles F. Sleep and Headache. Semin Neurol. 2009;29(4):406-418.  https://doi.org/10.1055/s-0029-1237113
  20. Drobizhev MYu, Fedotova AV, Kikta SV, Antohin EYu. Phenomenon of aminophenylbutyric acid. Russkii meditsinskii zhurnal. 2016;(24):1657-1663. (In Russ.).
  21. Baskin SM, Lipchik GL, Smitherman TA. Mood and Anxiety Disorders in Chronic Headache. Headache. 2006;46(suppl 3):76-87.  https://doi.org/10.1111/j.1526-4610.2006.00559.x
  22. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.  https://doi.org/10.1177/0333102417738202
  23. Torres-Ferrus M, Quintana M, Fernandez-Morales J, et al. When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month. Cephalalgia. 2017;37(2):104-113.  https://doi.org/10.1177/0333102416636055
  24. Golovacheva VA, Parfenov VA, Golovacheva AA. Cognitive complaints and cognitive impairment in patients with chronic daily headache. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2017;9(4):55-59. (In Russ.). https://doi.org/10.14412/2074-2711-2017-4-55-59
  25. Engstrøm M, Hagen K, Bjørk M, et al. Sleep-related and non-sleep-related migraine: interictal sleep quality, arousals and pain thresholds. J Headache Pain. 2013;14(1):68.  https://doi.org/10.1186/1129-2377-14-68
  26. Krisoffersen ES, Stavem K, Lundqvist C, Russel MB. Excessive daytime sleepiness in chronic migraine and chronic tension-type headache from general population. Cephalalgia. 2018;38(5):993-997.  https://doi.org/10.1177/0333102417721133
  27. Kristoffersen ES, Straand J, Russell MB, Lundqvist C. Disability, anxiety and depression in patients with medication-overuse headache in primary care — the BIMOH study. Eur J Neurol. 2016;23(suppl 1):28-35.  https://doi.org/10.1111/ene.12850
  28. Bendtsen L, Munksgaard S, Tassorelli C, et al. Disability, anxiety and depression associated with medication overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2013;34:426-433.  https://doi.org/10.1177/0333102413515338
  29. Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trondelag Health Studies. Pain. 2012;153:56-61.  https://doi.org/10.1016/j.pain.2011.08.018
  30. Griffith JL, Razavi M. Pharmacological Management of Mood and Anxiety Disorders in Headache Patients. Headache. 2006;46(suppl 3):133-141.  https://doi.org/10.1111/j.1526-4610.2006.00564.x
  31. Vorob’eva OV, Rusaya VV. Efficacy and safety of noophen in the treatment of chronic fatigue syndrome in patients with cerebrovascular insufficiency. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(11):31-36. (In Russ.). https://doi.org/10.17116/jnevro201711711131-36

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.